A Pilot Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia

BACKGROUND: Resistance to therapy and a poor outcome characterize relapsed or refractory acute myeloid leukemia (AML). There is a clear need for additional palliative approaches with acceptable toxicities. Vincristine sulfate liposome injection (VSLI) confers enhanced pharmacokinetics and activity w...

Descripción completa

Detalles Bibliográficos
Autores principales: Seegars, Mary Beth, Woods, Ryan, Ellis, Leslie R., Bhave, Rupali Roy, Howard, Dianna S., Manuel, Megan, Dralle, Sarah, Lyerly, Susan, Powell, Bayard L., Pardee, Timothy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891907/
https://www.ncbi.nlm.nih.gov/pubmed/33643502
http://dx.doi.org/10.14740/jh771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891907/
https://www.ncbi.nlm.nih.gov/pubmed/33643502
http://dx.doi.org/10.14740/jh771

Ejemplares similares